This stock has really gone sour and south. Not much joy since the granting of the CE mark. Come to think of it, not much joy before the CE Mark granting.
The real reason behind the dumping of their CEO is still a mystery and still none the wiser where their next sale/placement of the Oncosil device will occur. Within the next 6 to 9 months, one would expect the majority of the developed nations to be vaccinated, and for the TGA to either approve or reject Australian registration of the device. Still a very high risk play. I am in for the make or break outcome.
OSL Price at posting:
8.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)